| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.2 | 3e-09 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.21 | 6e-09 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.2 | 4e-08 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.16 | 4e-07 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.19 | 5e-07 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | 0.21 | 5e-07 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.25 | 4e-06 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.15 | 6e-06 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.15 | 1e-05 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | -0.17 | 1e-05 |